News Release

Associate Director of The Cancer Institute of New Jersey Elevated to Top Post on National Board

April 5, 2010

New Brunswick, N.J.–  The associate director of The Cancer Institute of New Jersey (CINJ), Bruce G. Haffty, MD, who is a professor and chair of the Department of Radiation Oncology at UMDNJ-Robert Wood Johnson Medical School, will assume the role of president of the American Board of Radiology following the organization’s board meeting in May. The American Board of Radiology is one of 27 boards of the American Board of Medical Specialties and oversees certification and maintenance of certification in diagnostic radiology, radiation oncology and radiologic physics. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

Dr. Haffty, a resident of Franklin Township, also is the chief of radiation oncology at CINJ and Robert Wood Johnson University Hospital in New Brunswick. He is being elevated to the top post following two years of service as president-elect. He has been a trustee of the American Board of Radiology since 2005 and has served in a number of critical roles within the organization. Haffty succeeds N. Reed Dunnick, MD, who is the chair of the Department of Radiology at the University of Michigan.

Along with being the author of more than 200 peer-reviewed articles, editorials and reviews, Haffty -- who is internationally recognized for his clinical expertise in breast cancer and his clinical and translational research in radiation oncology -- has edited and authored numerous books and book chapters.

A graduate of the Yale University School of medicine, Haffty completed an internship in internal medicine, followed by residency and chief residency in the Department of Therapeutic Radiology, Yale-New Haven Hospital. Prior to joining the faculty at UMDNJ-Robert Wood Johnson Medical School, he served at Yale as professor and vice chair, Department of Therapeutic Radiology, and director, Residency Training Program in Therapeutic Radiology.

Haffty also is a member of the editorial board of several medical journals, which includes his associate editor position of the Journal of Clinical Oncology. He also serves on the Board of Directors for the American Society of Radiation Oncology.


About The Cancer Institute of New Jersey

The Cancer Institute of New Jersey (www.cinj.org) is the state’s first and only National Cancer Institute-designated Comprehensive Cancer Center dedicated to improving the detection, treatment and care of patients with cancer, and serving as an education resource for cancer prevention. CINJ’s physician-scientists engage in translational research, transforming their laboratory discoveries into clinical practice, quite literally bringing research to life.  To make a tax-deductible gift to support CINJ, call 732-235-8614 or visit www.cinjfoundation.org. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School. 

The CINJ Network is comprised of hospitals throughout the state and provides a mechanism to rapidly disseminate important discoveries into the community. Flagship Hospital: Robert Wood Johnson University Hospital. Major Clinical Research Affiliate Hospitals: Carol G. Simon Cancer Center at Morristown Memorial Hospital, Carol G. Simon Cancer Center at Overlook Hospital, Cooper University Hospital and Jersey Shore University Medical Center. Affiliate Hospitals: Bayshore Community Hospital, CentraState Healthcare System, JFK Medical Center, Mountainside Hospital, Raritan Bay Medical Center, Robert Wood Johnson University Hospital at Hamilton (CINJ at Hamilton), Saint Peter’s University Hospital, Somerset Medical Center, Southern Ocean County Hospital, The University Hospital/UMDNJ-New Jersey Medical School*, and University Medical Center at Princeton. *Academic Affiliate

 

 

Contact: 
Michele Fisher
Phone: 
732-235-9872